title: Carrying one or two reduced-function CYP2C19 alleles is associated with an increased risk of major adverse cardiovascular events in people undergoing percutaneous coronary intervention and treated with clopidogrel.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
authors.forename: Andrea H
authors.initials: AH
authors.lastname: Ramirez
authors.forename: Jessica T
authors.initials: JT
authors.lastname: Delaney
authors.forename: Alan R
authors.initials: AR
authors.lastname: Shuldiner